Evidence map›Paper›PMID 40732232›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Protective Effects of Pasireotide in LPS-Induced Acute Lung Injury.

Saikat Fakir, Md Matiur Rahman Sarker, Madan Sigdel, Nektarios Barabutis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saikat FakirSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.ORCID 0009-0007-4103-6260
Md Matiur Rahman SarkerSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.ORCID 0009-0009-2817-7987
Madan SigdelSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.
Nektarios BarabutisSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.ORCID 0000-0001-8366-5099

Funding

STABILITY' (symptomatic review during biologic therapy) Review in Inflammatory Bowel DiseaseP20GM103424 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI VLADIMIR N CHOULJENKO · 2012 to 2026
$57.4M
Synthetic Somatostatin Analogs Protect Against Endothelial Barrier DysfunctionR03AI176433 · NIAID · UNIVERSITY OF LOUISIANA AT MONROE · PI BARABUTIS, NEKTARIOS · 2024 to 2025
$145k
NIAID/NIH R03AI176433NIAID NIH HHS R03 AI176433NIGMS/NIH P2O GM103424-21NIGMS NIH HHS P20 GM103424
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

growth hormonehomeostasisinflammationsepsisSomatostatin

Identifiers

PMID40732232
PMCPMC12298338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.